Effect of darbepoetin alfa on quality of life in anemia of chronic kidney disease elderly patients with type 2 diabetes mellitus
- Conditions
- Renal anemia with type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000007693
- Lead Sponsor
- Graduate School of Medicine, Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Not provided
1) Patients with cognitive impairment and on the anti cognitive impairment drug 2) Patients with impossible control of hypertension 3) Patients with impossible glycemic control 4) Patients with congestive heart failure 5) Patients with major surgery within 16 weeks 6) Patients with red blood cell (RBC) transfusions within 16 weeks 7) Patients receiving anabolic steroid hormone, testosterone enanthate, mepitiostane within 16 weeks 8) Patients with anemia caused by conditions other than renal anemia such as GI bleeding and blood desease 9) Patients with history of stroke, MI or other sever vascular complication which required a hospitalization 10) Patients with serious allergies or serious drug sensitivities 11) Patients with serious liver dysfunction (ALT or AST greater than 2 times the upper limit of hpspital standard) 12) Patients with scheduled to receive a renal replacement therapy 13) Patients having hypersensitivity to rHuEPO 14) Other patients determined to be inappropriate by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method